Sutent sunitinib: Phase III discontinued

Pfizer terminated the Phase III SUN 1107 trial after an IDMC reported that Sutent would be unable to meet the primary endpoint of PFS vs. Xeloda capecitabine from Roche (SIX:ROG, Basel, Switzerland)...